Unexplained left ventricular hypertrophy: consider a diagnosis of Fabry's disease

G.E. Linthorst, A.C. Vedder, B.J. Bouma, L.R.C. Dekker, C.E.M. Hollak

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Abstract

Lysosomal storage disorders are a group of disorders characterised by the deficiency of a specific lysosomal hydrolase. These diseases are rare, with only a few hundred patients in the Netherlands. Fabry's disease, an X-linked lysosomal storage disorder, is caused by a deficiency of the lysosomal enzyme α-galactosidase A which results in, among other things, left ventricular hypertrophy, renal failure and cerebrovascular events. Patients with Fabry's disease, especially males, have a decreased life expectancy. Recent studies have shown that Fabry's disease may be much more common among patients with left ventricular hypertrophy (LVH) than previously thought. Up to 7% of male patients with left ventricular hypertrophy and up to 12% of female patients with unexplained LVH were found to suffer from Fabry's disease. Thus, Fabry's disease should be considered in patients with unexplained LVH. This case report summarises the main features of the disease. In addition recent developments concerning prevalence, diagnosis and the current available treatments are discussed and an algorithm on who and how to screen for Fabry's disease is presented.

Original languageEnglish
Pages (from-to)100-105
Number of pages6
JournalNetherlands Heart Journal
Volume14
Issue number3
Publication statusPublished - Mar 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Unexplained left ventricular hypertrophy: consider a diagnosis of Fabry's disease'. Together they form a unique fingerprint.

Cite this